SEC Form 4 · accession 0001209191-18-014228
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea van Elsas
Officer — Chief Scientific Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 27, 2018 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2018 | S | 6,874 | $6.4768 | D | 216,669 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares sold to cover the tax obligation that occurred upon the vesting of the Restricted Stock Units granted to Reporting Person on February 23, 2017 for 51,700 shares.